MARTINUZZI, CLAUDIA
 Distribuzione geografica
Continente #
EU - Europa 1.891
AS - Asia 20
SA - Sud America 3
Totale 1.914
Nazione #
IT - Italia 1.891
CN - Cina 19
BR - Brasile 3
SG - Singapore 1
Totale 1.914
Città #
Genova 850
Genoa 744
Rapallo 177
Vado Ligure 117
Beijing 6
Bordighera 3
Caxias do Sul 1
Saquarema 1
Singapore 1
Ubá 1
Totale 1.901
Nome #
Heterogeneity and frequency of BRAF mutations in primary melanoma: Comparison between molecular methods and immunohistochemistry 215
A combination of immunohistochemistry and molecular approaches improves highly sensitive detection of BRAF mutations in papillary thyroid cancer 194
Combining molecular and immunohistochemical analyses of key drivers in primary melanomas: Interplay between germline and somatic variations 181
Mutation Analysis of PRKAR1A Gene in a Patient with Atrial Myxoma 174
Multiple primary melanomas (MPMs) and criteria for genetic assessment: MultiMEL, a multicenter study of the Italian Melanoma Intergroup 169
The new small tyrosine-kinase inhibitor ARQ531 targets acute myeloid leukemia cells by disrupting multiple tumor-addicted programs 145
Molecular characterization of an Italian series of sporadic GISTs. 144
Correction: Combining molecular and immunohistochemical analyses of key drivers in primary melanomas: Interplay between germline and somatic variations [Oncotarget. 2018; 9:5691-5702]doi 10.18632/oncotarget.23204 128
Absence of high risk gene mutations in hereditary melanoma points to the interplay between somatic and low risk germline variants 126
Amino acid depletion triggered by L-asparaginase sensitizes MM cells to carfilzomib by inducing mitochondria ROS-mediated cell death 118
CD38-Induced Metabolic Dysfunction Primes Multiple Myeloma Cells for NAD+-Lowering Agents 117
A novel PTCH1 gene mutation in a pediatric patient associated multiple keratocystic odontogenic tumors of the jaws and Gorlin-Goltz syndrome 117
NAD+ METABOLISM RESTRICTION BOOSTS HIGH-DOSE MELPHALAN EFFICACY IN PATIENTS WITH MULTIPLE MYELOMA 84
Higher CD56 Expression on Multiple Myeloma Cells Increases CD38 Expression, Reduces Intracellular NAD+ Levels, and Enhances the Efficacy of Daratumumab-Based Treatment Strategies 35
The NAD + Metabolic Dependency Restriction Overcomes Drug-Resistance Phenotype of Multiple Myeloma CELLS 26
Totale 1.973
Categoria #
all - tutte 6.538
article - articoli 5.945
book - libri 0
conference - conferenze 593
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.076


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021117 0 0 0 7 17 14 8 6 19 20 20 6
2021/2022165 5 5 11 20 12 20 12 29 14 19 2 16
2022/2023220 23 24 8 23 34 31 0 14 17 8 36 2
2023/2024159 3 17 7 23 9 32 8 18 4 7 8 23
2024/2025404 14 18 8 33 29 36 48 85 9 28 47 49
2025/2026291 106 27 85 73 0 0 0 0 0 0 0 0
Totale 1.973